Determining the role of radiotherapy in the adjuvant management of gastric cancer: an ocean apart Benjamin W. CornRavit Geva Editorial 20 February 2010 Pages: 1005 - 1007
A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer Aristotelis BamiasM. KarinaG. Fountzilas Original Article 04 February 2010 Pages: 1009 - 1021
Erlotinib as salvage treatment after failure to first-line gefitinib in non-small cell lung cancer Matthew K. WongAlvis I. LoJames C. Ho Original Article Open access 13 August 2009 Pages: 1023 - 1028
Beneficial effect of metronomic chemotherapy on tumor suppression and survival in a rat model of hepatocellular carcinoma with liver cirrhosis Seong Tae ParkJeong Won JangSeung Kew Yoon Original Article 23 August 2009 Pages: 1029 - 1037
LLL-3, a STAT3 inhibitor, represses BCR-ABL-positive cell proliferation, activates apoptosis and improves the effects of Imatinib mesylate Andre Luiz MencalhaB. Du RocherE. Abdelhay Original Article 23 August 2009 Pages: 1039 - 1046
Differential roles of Trk and p75 neurotrophin receptors in tumorigenesis and chemoresistance ex vivo and in vivo Muriel BassiliElena BirmanH. Uri Saragovi Original Article 22 August 2009 Pages: 1047 - 1056
Pharmacokinetics of carboplatin and etoposide in infant neuroblastoma patients Gareth J. VealMichael ColeAlan V. Boddy Original Article 23 August 2009 Pages: 1057 - 1066
The role of the polyamine catabolic enzymes SSAT and SMO in the synergistic effects of standard chemotherapeutic agents with a polyamine analogue in human breast cancer cell lines Allison Pledgie-TracyMadhavi BillamNancy E. Davidson Original Article 30 August 2009 Pages: 1067 - 1081
In vitro comparison of O4-benzylfolate modulated, BCNU-induced toxicity in human bone marrow using CFU-GM and tumor cell lines Holger Peter BehrsingMichael J. FurnissRalph E. Parchment Original Article 29 August 2009 Pages: 1083 - 1091
Phase II study of S-1 as first-line treatment for elderly patients over 75 years of age with advanced gastric cancer: the Tokyo Cooperative Oncology Group study Wasaburo KoizumiToshikazu AkiyaMinoru Kurihara Original Article 30 August 2009 Pages: 1093 - 1099
Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer Takashi SasakiHiroyuki IsayamaMasao Omata Original Article 26 August 2009 Pages: 1101 - 1107
Pharmacokinetics and enhanced bioavailability of candidate cancer preventative agent, SR13668 in dogs and monkeys Izet M. KapetanovicMiguel MuzzioDavid L. McCormick Original Article 16 September 2009 Pages: 1109 - 1116
Oxidative stress and enhanced paracellular permeability in the small intestine of methotrexate-treated rats Tomoko MaedaYuko MiyazonoToshiharu Horie Original Article 16 September 2009 Pages: 1117 - 1123
Clinical potency of methotrexate, aminopterin, talotrexin and pemetrexed in childhood leukemias Robin E. NorrisPeter C. Adamson Original Article 27 September 2009 Pages: 1125 - 1130
PSC833, cyclosporine analogue, downregulates MDR1 expression by activating JNK/c-Jun/AP-1 and suppressing NF-κB H. BarkCheol-Hee Choi Original Article 18 September 2009 Pages: 1131 - 1136
Zoledronic acid in the treatment of bone metastases by hepatocellular carcinoma: a case series Liliana MontellaRaffaele AddeoSalvatore Del Prete Original Article 16 September 2009 Pages: 1137 - 1143
Pharmacokinetics and distribution of SN 28049, a novel DNA binding anticancer agent, in mice Pradeep B. LukkaJames W. PaxtonBruce C. Baguley Original Article 23 September 2009 Pages: 1145 - 1152
Heterogeneity of epithelial and stromal cells of head and neck squamous cell carcinomas in ex vivo chemoresponse Iris-Susanne HornGunnar WichmannAndreas Boehm Original Article 22 September 2009 Pages: 1153 - 1163
Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data Anne von HeidemanÅke BerglundPeter Nygren Original Article 30 September 2009 Pages: 1165 - 1172
Medulloblastoma in childhood: revisiting intrathecal therapy in infants and children Sharon ConroyMartin GarnettDavid Walker Original Article 24 October 2009 Pages: 1173 - 1189
Novel d-erythro N-octanoyl sphingosine analogs as chemo- and endocrine-resistant breast cancer therapeutics James W. AntoonJiawang LiuBarbara S. Beckman Short Communication 14 February 2010 Pages: 1191 - 1195
Pharmacokinetic study of gemcitabine, given as prolonged infusion at fixed dose rate, in combination with cisplatin in patients with advanced non-small-cell lung cancer Orazio CaffoStefania FallaniEnzo Galligioni Short Communication 06 February 2010 Pages: 1197 - 1202
Population pharmacokinetic study of a test dose oral busulfan in Japanese adult patients undergoing hematopoietic stem cell transplantation Yasushi TakamatsuNoriaki SasakiKazuo Tamura Short Communication 19 February 2010 Pages: 1203 - 1207